GlyCardial Diagnostics incorporates Dr. Andreas Calatzis as non-executive Chairman of the Board of Directors.
GlyCardial Diagnostics attended the EIT Health annual meeting at IESE Business School together with EIT health partners and entrepreneurs.
GlyCardial Diagnostics receives 1.9M€ from the SME Instrument Phase II H2020 Programme to advance in the development of the novel test for the early detection of cardiac ischemia.
GlyCardial Diagnostics has been granted with a Retos-Colaboración project from the Ministerio de Ciencia, Innovación y Universidades that will be carried out in collaboration with the Sant Pau Research Institute.
GlyCardial Diagnostics S.L. launches a new web page designed by 021 Informàtics.
Detecting cardiac ischemia: A new test could diagnose these cardiovascular events in early stages minimizing their consequences.
GlyCardial Diagnostics secures 2.4M€ in its first funding round to develop the first blood test to detect the early stages of cardiac ischemia.
GlyCardial Diagnostics S.L. incorporation to develop the first test for the early diagnosis and prognosis of cardiac ischemic events.